Brief: GlycoMimetics Reports Highlights and Financial Results for Q1 2022
28/04/2022 12:53
April 28 (Reuters) - GlycoMimetics Inc GLYC.O :
* GLYCOMIMETICS REPORTS HIGHLIGHTS AND FINANCIAL RESULTS FOR
FIRST
QUARTER 2022
* GLYCOMIMETICS INC - AS OF MARCH 31, 2022, GLYCOMIMETICS
HAD CASH
AND CASH EQUIVALENTS OF $76.5 MILLION
* GLYCOMIMETICS INC QTRLY LOSS PER SHARE $0.28
Source text for Eikon: ID:nBw5sjLLma
Further company coverage: GLYC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering